Skip to content

Drug interactions

Empagliflozin + Insulin detemir

Severity: Moderate

Empagliflozin and Insulin detemir: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Empagliflozin lowers glucose independently of insulin, so adding it to insulin detemir increases the risk of hypoglycemia. The combination is commonly used, but insulin doses often need to be reduced when the SGLT2 inhibitor is started.

What this interaction means in plain words

Empagliflozin and Insulin detemir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Empagliflozin belongs to Endocrine; Insulin detemir belongs to Endocrine.

Evidence level: High

Why it happens

Additive glucose lowering through insulin action plus SGLT2-mediated urinary glucose excretion.

What to do

Consider lowering the insulin detemir dose when starting empagliflozin and monitor blood glucose closely. Also counsel on ketoacidosis symptoms, particularly if insulin doses are reduced substantially.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Empagliflozin and Insulin detemir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Empagliflozin with Insulin detemir?

MediHelp rates the interaction as moderate. Empagliflozin and Insulin detemir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Empagliflozin lowers glucose independently of insulin, so adding it to insulin detemir increases the risk of hypoglycemia. The combination is commonly used, but insulin doses often need to be reduced when the SGLT2 inhibitor is started.

How serious is the interaction between Empagliflozin and Insulin detemir?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider lowering the insulin detemir dose when starting empagliflozin and monitor blood glucose closely. Also counsel on ketoacidosis symptoms, particularly if insulin doses are reduced substantially.

What other medicines interact with Insulin detemir?

MediHelp also lists interactions of Insulin detemir with, for example, Alogliptin-pioglitazone, Ethanol, Glimepiride-pioglitazone. The full list is on the Insulin detemir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in